Related Experiment Video
Updated: Mar 12, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic
Paul G Thomes1, Elizabeth Brandon-Warner1, Ting Li1
1Department of Internal Medicine, Carolinas Medical Center, Charlotte, NC, USA.
Abstract:
We demonstrated that ligand-activated nuclear receptor Rev-erbα mitigates CCl4-induced liver fibrosis. Rev-erbα is also a novel regulator of autophagy, a crucial eukaryotic catabolic system in which lysosomes degrade substrates for energy generation. In hepatic stellate cells (HSC) autophagy is reportedly required for this purpose to activate HSCs during fibrogenesis. Here, we examined whether pharmacological activation of Rev-erb with its synthetic ligand SR9009 or treatment with the pro-fibrotic cytokine, TGF-β, each differentially modulate autophagy to regulate the HSC phenotype. We measured the effects of SR9009 on autophagy markers in a CCl4-induced liver fibrosis model. Using primary and immortalized HSCs in vitro, we quantified SR9009 and TGF-β effects on autophagy flux. Compared with vehicle-treated controls, livers from CCl4-treated mice exhibited lower AMPK, higher P70S6K phosphorylation, elevated P62 and lower levels of ATG proteins, indicating a disruption of autophagosome (AV) formation. SR9009 treatment prevented CCl4-induced P70S6K phosphorylation but did not affect CCl4-induced changes in AMPK, ATG proteins or P62. Analysis of autophagy markers and autophagy flux in primary HSCs or an immortalized human HSC line (LX2), revealed that SR9009 exposure down-regulated AV biogenesis. These events were associated with lower levels of fibrogenic gene expression, P70S6K phosphorylation and HSC proliferation. However, HSC exposure to TGF-β enhanced fibrogenic gene expression, P70S6K phosphorylation and HSC proliferation, while it simultaneously decelerated AV synthesis. The autophagy activator rapamycin and the autophagy inhibitor wortmannin each decreased HSC activation, P70S6K phosphorylation and HSC proliferation. Furthermore, knock-down of P70S6K using siRNA blocked basal and TGF-β-induced cell proliferation in human activated LX2. We conclude that SR9009 and TGF-β both similarly affected autophagy but, differentially regulated HSC fibrogenic phenotype through modulation of P70S6K, which is crucial for cell proliferation and fibrogenesis.
Insights
Ligand-activated nuclear receptor Rev-erbα mitigates liver fibrosis by regulating autophagy and hepatic stellate cell (HSC) phenotype. SR9009 and TGF-β differentially modulate autophagy, impacting HSC proliferation and fibrogenesis via P70S6K signaling.
Area of Science:
- Hepatology and molecular biology
- Cellular metabolism and signaling
Background:
- Liver fibrosis is a significant health concern driven by hepatic stellate cell (HSC) activation.
- Autophagy, a cellular degradation process, plays a complex role in HSC activation and fibrogenesis.
- Nuclear receptor Rev-erbα has emerged as a potential regulator of liver fibrosis and autophagy.
Purpose of the Study:
- To investigate the differential effects of Rev-erbα activation (using SR9009) and TGF-β on autophagy in HSCs.
- To elucidate the role of autophagy modulation in regulating HSC phenotype, proliferation, and fibrogenesis.
- To determine the involvement of P70S6K signaling in these processes.
Main Methods:
- Utilized a carbon tetrachloride (CCl4)-induced liver fibrosis mouse model to assess autophagy markers.
- Employed primary and immortalized human HSCs (LX2) for in vitro studies on autophagy flux and gene expression.
- Measured autophagy markers (AMPK, P70S6K, P62, ATG proteins), fibrogenic gene expression, and cell proliferation.
- Investigated the effects of SR9009, TGF-β, rapamycin, wortmannin, and P70S6K knockdown (siRNA).
Main Results:
- CCl4-induced liver fibrosis disrupted autophagosome formation, characterized by altered autophagy markers.
- SR9009 treatment prevented CCl4-induced P70S6K phosphorylation and down-regulated autophagosome biogenesis in HSCs, reducing fibrogenic gene expression and proliferation.
- TGF-β enhanced fibrogenic gene expression and HSC proliferation while decelerating autophagosome synthesis.
- Both autophagy modulation (rapamycin, wortmannin) and P70S6K knockdown inhibited HSC activation and proliferation.
Conclusions:
- SR9009 and TGF-β differentially regulate HSC fibrogenic phenotype through P70S6K modulation, despite similar effects on autophagy.
- P70S6K is a crucial mediator of cell proliferation and fibrogenesis in HSCs.
- Targeting Rev-erbα or P70S6K signaling presents a potential therapeutic strategy for liver fibrosis.
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway

